Health
5.2
Brazil caps semestral HIV injection at R$20,914; not in SUS
Published 1 d ago1 sourceEvidence: Reported
SeverityModeratePoder360BR
Brazil's health regulator Anvisa ordered seizure of a counterfeit batch of botulinum toxin, prohibiting sale, distribution, or use. The action follows detection of a fake product in the market, posing potential health risks. The scope of distribution and any reported adverse effects remain unclear.
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago11 sourcesEvidence: Reported
Published 15 h ago5 sourcesEvidence: Reported
Published 9 h ago5 sourcesEvidence: Reported
Published 21 h ago6 sourcesEvidence: Reported
Published 1 d ago5 sourcesEvidence: Reported
Published 10 h ago5 sourcesEvidence: Reported
Published 1 d ago4 sourcesEvidence: Unknown